1.. Introduction {#s1}
================

Iron deficiency anemia is the most common nutritional deficiency in the world and brings with it negative consequences on growth and health \[[@B1],[@B2]\]. In developing countries, the prevalence of anemia is widespread in children, and three to four times higher than in developed countries \[[@B3],[@B4]\], making it a significant public health problem worldwide. The World Health Organization (WHO) estimated the national prevalence of anemia in South Africa (Hb \<11 g/dl) to be 24.1% (WHO, 2008). Also, there have been three national nutritional surveys in the last 20 years and comparing the results of the three surveys shows that iron deficiency with or without anemia is prevalent in the country ranging from 5% to 14.3% \[[@B5]--[@B7]\]. The studies have reported the prevalence of anemia to be between 21% and 27.9% in children \[[@B5]--[@B7]\]. With regard to iron intake, it was reported that 25%-37% of children between the ages of 1 and 9 years had less than the recommended daily allowance, whereas 36--57% had iron intakes of less than two-thirds of the recommended daily allowance (RDA) \[[@B6]\]. The prevalence of poor iron status in children appeared to have increased when compared with previous national data \[[@B5]\], which point to the fact that the iron status of children in South Africa was deteriorating.

It is well recognized that the consequences of iron deficiency with or without anemia include increased susceptibility to infection owing to impaired immune function, poor growth development, reduced work capacity and mental performance, retardation of psychomotor development and reduced learning capacity \[[@B8]\]. Experimental evidence in the last decade showed that iron regulates the function of T-lymphocytes, and in most studies, a deficiency results in impaired cell-mediated immunity \[[@B9]--[@B12]\]. Iron deficiency may also delay the normal development of the cell-mediated immunity \[[@B9]\]. The various mechanisms that could explain the effects of iron deficiency on the immune system have been highlighted and reviewed by several authors \[[@B9],[@B11]\].

Several studies have examined the associations between iron status and immune response in different populations \[[@B13]--[@B19]\], most of which were conducted on infants, adults and women. It has been shown that measures of iron status such as ferritin, which is an acute-phase protein, are elevated in the presence of infection or inflammation \[[@B20]\]. Despite indications of a high prevalence of iron deficiency, the effect of iron deficiency on immune response in schoolchildren has not been well elucidated, especially when using white blood cell counts as immune markers. However, because of the high prevalence of iron deficiency among South African children, it is probable that cell-mediated immune response may be impaired in many of these children, which will be reflected as abnormal differential white blood cell counts. This study, therefore, examined the associations between iron status and immune response as measured by differential white blood cell counts in apparently healthy African schoolchildren.

2.. Subjects and methods {#s2}
========================

2.1.. Study design {#s2.1}
------------------

The study was a cross-sectional study done in the North-West province of South Africa, not known to be a malaria endemic area. The selection of the study sites was the result of a consultation process with the most important stakeholders taking all priorities into account. Study sites were comprised of three primary schools in Jouberton in the greater KOSH (Klerksdorp, Orkney, Stilfontein, Hartebeesfontein) municipal area. The specific schools were identified in collaboration with the KOSH area Department of Education. Efforts were made to identify the most needy schools as these stood to benefit the most from the micronutrients to be provided. Three primary schools in Jouberton in the Matlosana municipal area of the North-West province of South Africa were included in the study. This study made use of the baseline data from the BeForMi multiple micronutrient beverage intervention study. Of the 1106 learners enrolled in the schools, 547 were excluded based on their age and 10 were not present during the days of measurements. The study population consisted of 556 schoolchildren between the ages of 7 and 10 years. This study was conducted according to the guidelines laid down in the Declaration of Helsinki. Written informed consent was obtained from the parents of each child, and oral assent was obtained from each child. Permission to undertake the study was obtained from the Ethics Committees of the North-West University (**Research Ethics number: NWU-00065-09-A1).** The study was registered with the North-West Provincial Department of Health before the beginning of the study.

2.2.. Demographic and anthropometric measurements {#s2.2}
-------------------------------------------------

Demographic information was collected using a validated structured questionnaire, and the children's anthropometric measurements were done by trained anthropometrists, with the subjects barefoot and in their underwear. Boys' and girls' anthropometric measurements were performed separately in a private room. Weight was measured on a portable electronic scale (Precision Health Scale, A&D Company, Saitama, Japan) and height was measured with a stadiometer (IP 1465, Invicta, London, UK), with the subjects standing upright with their heads in the Frankfort plane. *Z*-Scores were calculated by using WHO Anthro Plus software (version 1.0.4).

2.3.. Collection of blood samples and laboratory analysis {#s2.3}
---------------------------------------------------------

Venous blood samples (10 ml) were collected and delivered in two containers as follows: (i) 4 ml blood was collected in EDTA-containing tube for hemoglobin (Hb) and full blood count; (ii) 6 ml blood was collected in coagulant free tubes and centrifuged for the estimation of serum ferritin (SF), serum transferrin receptor (sTfR) and C-reactive protein (CRP). Hemoglobin (Hb) and full blood count (WBC, RBC, MCV, neutrophils, lymphocytes, monocytes, eosinophils and basophils) were measured at North West University Nutrition laboratory using an AcT 5diff Cap Pierce Hematology Analyzer (Beckam Coulter, Miami, Florida, USA), using 3-level controls provided by the manufacturer, within 2 h of blood sampling. Zinc Protoporphyrin (ZnPP) analysis was measured on washed red blood cells (from the EDTA tubes) using a hematofluorometer (Aviv Biomedical, Lakewood, NJ, USA) and 3-level control material provided by the manufacturer. Enzyme-linked immunosorbent assays were used to measure sTfR and SF (Ramco Laboratories, Inc, Stafford, Texas). CRP was measured by immunoturbidimetric test (Human Biochemical and Diagnostical Laboratories, South Africa). The coefficients of variance (CV) for all assays were \<10%.

2.4.. Statistical analyses {#s2.4}
--------------------------

Data were analyzed using the Statistical Package for Social Sciences (SPSS) version 18 package. The data were log transformed and after log transformation most were still not normally distributed, hence non-parametric tests were used for the analysis. The results are presented as medians and interquartile ranges (IQR). Spearman's correlations were used to assess the relationships between indices of iron status (SF, TfR, transferrin to serum ferritin \[TfR/SF\] ratio), Hb and ZnPP) and other hematological parameters (RBC, WBC, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils). Additionally, for both genders, SF was used to divide subjects into two groups to ascertain if iron depletion affects differential WBC count--Group 1: SF \<12 μg/L; Group 2: SF between 12--150 μg/L; and differential WBC counts were compared. These cut-off points were used as they are the clinical cut-off points recommended for standard dietetics practice \[[@B21]\] and have been successfully used by Gopane et al. \[[@B22]\]. For both genders, Mann--Whitney *U* test was used to assess differences in WBC counts between the two SF groups (*p* \< 0.05 was considered statistically significant).

3.. Results {#s3}
===========

The baseline clinical and anthropometric characteristics of the 556 children who participated in the study are presented in [Table 1](#T1){ref-type="table"}. The median age for both males and females was 8 years, and 53% of the participants were boys. The results revealed no significant differences in most parameters between boys and girls with the exception of CRP (*p* = 0.004) and eosinophils (*p* = 0.042) which were higher in boys, whereas Hb (*p* = 0.023) and RBC (*p* = 0.018) were higher in girls. The measured iron markers' median values were within the normal reference values. White blood cell (WBC) and red blood cell (RBC) medians were within the normal reference values \[[@B21]\] in both genders ([Table 1](#T1){ref-type="table"}). Also, the differential WBCs were within the normal reference values with the exception of monocytes, which were slightly lower than normal values in both boys and girls ([Table 1](#T1){ref-type="table"}).

###### 

Clinical and anthropometric characteristics of the children according to gender.

  Variables                  Boys (*N* = 283)   Girls (*N* = 273)   Normal reference range (20)   *P* value
  -------------------------- ------------------ ------------------- ----------------------------- -----------
  Age (years)                8.05 (1.20)        8.27(1.35)                                        NS
  BAZ                        −0.57(1.32)        −0.52(1.53)                                       NS
  HAZ                        −1.04 (1.40)       −0.75 (1.18)                                      NS
  WAZ                        −1.05 (1.50)       −0.83 (1.49)                                      NS
  Serum ferritin (μg/l)      24.74(21.72)       26.90(28.29)        12--150                       NS
  TfR (μg/l)                 5.77(1.69)         5.69(1.65)          2.9--8.3                      NS
  TfR/Serum ferritin ratio   0.24(0.24)         0.21(0.28)          \>0.975                       NS
  CRP (mg/l)                 3.70(3.10)         3.30(2.70)          3--10                         0.004
  ZnPP (μmol/mol heme)       56.00(21.38)       56.00(24.50)        \<40                          NS
  RBC (1,000,000/μl)         4.58(0.47)         4.74(0.47)          3.5--5.0                      0.018
  WBC (1000/μl)              6.80(2.70)         6.90(2.70)          4.0--11.0                     NS
  Hb (g/dl)                  12.60(1.20)        12.80(1.15)         11.5--13.0                    0.023
  MCV (fL)                   83.00(5.00)        83.00(6.00)         76--96                        NS
  Neutrophils (1000/μl)      2.78(2.20)         2.80(2.02)          2.0--7.5                      NS
  Lymphocytes (1000/μl)      3.02(1.10)         2.87(1.01)          1.5--4.0                      NS
  Monocytes (1000/μl)        0.45(0.22)         0.43(0.19)          0.5--1.5                      NS
  Eosinophils (1000/μl)      0.34(0.36)         0.29(0.30)          0.04--0.4                     0.042
  Basophils (1000/μl)        0.03(0.02)         0.04(0.02)          0.0--0.1                      NS

*N* = number, IQR = Interquartile range, BAZ = BMI-for-age *z*-score, TfR = Transferrin receptor, HAZ = Height-for-age *z*-score, WAZ = Weight-for-age z-score, CRP = C-reactive protein, ZnPP = Zinc protoporphyrin, RBC = red blood cell, WBC = white blood cell, MCV = mean cell volume, Hb = Hemoglobin, NS: Not significant.

[Table 2](#T2){ref-type="table"} shows the classification of the children according to their iron status. The overall prevalence of anemia (Hb \<11.5 g/dl) was 6.8%, iron deficiency (Hb ⩾11.5 g/dl and SF \<12 μg/L) was present in 13.9% and iron deficiency anemia (Hb \<11.5 g/dl ans SF \<12 μg/L) was present in 5.6% of the children.

###### 

Classification of the children according to iron status.

  Diagnosis/condition      Indicators \[[@B7]\]                       Total *N* (%)   Females (*n* = 273)   Males (*m* = 283)
  ------------------------ ------------------------------------------ --------------- --------------------- -------------------
  Anemia                   Hb \<11.5 g/dl                             38 (6.8)        22 (8.0)              16 (5.6)
  Iron deficiency          Hb ⩾11.5 g/dl & Serum ferritin \<12 μg/L   77 (13.9)       36 (13.2)             41 (14.5)
  Iron deficiency Anemia   Hb \<11.5 g/dl &Serum ferritin \<12 μg/L   31(5.6)         17 (6.2)              15 (5.3)
  Iron sufficient          Hb ⩾11.5 g/dl & Serum ferritin ⩾12 μg/L    410 (73.7)      198(72.5)             210 (74.2)

*N* = Number.

Correlations between the measured iron markers, CRP and hematological parameters in the total group are displayed in [Table 3](#T3){ref-type="table"}. SF correlated positively with weight-for-age *z*-score (WAZ) (*r* = 0.124, *p* \< 0.01), Hb (*r* = 0.191, *p* \< 0.01), CRP (*r* = 0.167, *p* \< 0.01), and MCV (*r* = 0.159, *p* \< 0.01). No correlations were observed between any iron markers and differential WBC counts. [Table 4](#T4){ref-type="table"} shows the correlations between iron markers, CRP and hematological parameters after splitting by gender. A positive correlation was observed between SF and CRP in girls only (*r* = 0.336, *p* \< 0.01), and a positive correlation between SF and MCV in boys only (*r* = 0.197, *p* \< 0.01). In both genders, no correlations were observed between the different iron markers and differential WBC counts. In both genders adjusting for CRP levels did not change the associations observed.

###### 

Correlations (*r*~s~) between markers of iron status, CRP; and hematological and anthropometric parameters of children (*N* = 556).

  Variable        Ferritin                                     TfR                                          TfR/Ferritin                                 HB                                          ZnPP     CRP
  --------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- ------------------------------------------- -------- --------------------------------------------
  Age             0.258[^\*\*^](#TFN4){ref-type="table-fn"}    −0.086[^\*^](#TFN5){ref-type="table-fn"}     −0.249[^\*\*^](#TFN4){ref-type="table-fn"}   0.194[^\*^](#TFN5){ref-type="table-fn"}     0.032    0.050
  BAZ             0.051                                        0.042                                        −0.054                                       0.054                                       0.067    0.141
  WAZ             0.124[^\*\*^](#TFN4){ref-type="table-fn"}    0.078                                        −0.031                                       0.214[^\*\*^](#TFN4){ref-type="table-fn"}   0.051    0.083
  HAZ             0.074                                        0.085                                        −0.074                                       0.231[^\*\*^](#TFN4){ref-type="table-fn"}   0.009    0.052
  Ferritin        --                                           −0.285[^\*\*^](#TFN4){ref-type="table-fn"}   −0.967[^\*\*^](#TFN4){ref-type="table-fn"}   0.191[^\*\*^](#TFN4){ref-type="table-fn"}   0.007    0.167[^\*\*^](#TFN4){ref-type="table-fn"}
  TfR             −0.285[^\*\*^](#TFN4){ref-type="table-fn"}   --                                           0.490[^\*^](#TFN5){ref-type="table-fn"}      −0.017                                      0.029    0.001
  TfR/ratio plu   −0.967[^\*\*^](#TFN4){ref-type="table-fn"}   0.490[^\*\*^](#TFN4){ref-type="table-fn"}    --                                           −0.177[^\*^](#TFN5){ref-type="table-fn"}    0.010    −0.149[^\*\*^](#TFN4){ref-type="table-fn"}
  CRP             0.167[^\*\*^](#TFN4){ref-type="table-fn"}    0.001                                        −0.149[^\*\*^](#TFN4){ref-type="table-fn"}   −0.005                                      −0.073   --
  ZnPP            0.007                                        0.029                                        0.010                                        −0.026                                      −        −0.073
  RBC             0.023                                        0.149[^\*\*^](#TFN4){ref-type="table-fn"}    −0.006                                       0.640[^\*\*^](#TFN4){ref-type="table-fn"}   −0.015   −0.046
  WBC             −0.049                                       −0.014                                       0.032                                        −0.044                                      −0.049   −0.038
  Hb              0.191[^\*\*^](#TFN4){ref-type="table-fn"}    −0.017                                       −0.177[^\*\*^](#TFN4){ref-type="table-fn"}   --                                          −0.026   −0.005
  MCV             0.159[^\*\*^](#TFN4){ref-type="table-fn"}    −0.188[^\*\*^](#TFN4){ref-type="table-fn"}   −0.165[^\*\*^](#TFN4){ref-type="table-fn"}   0.274[^\*^](#TFN5){ref-type="table-fn"}     0.000    0.008
  Neutrophils     −0.071                                       −0.030                                       0.054                                        −0.032                                      −0.054   −0.062
  Lymphocytes     −0.045                                       0.013                                        0.039                                        0.034                                       −0.051   −0.008
  Monocytes       −0.021                                       −0.015                                       −0.007                                       −0.036                                      −0.061   0.007
  Eosinophils     −0.024                                       0.007                                        0.015                                        0.004                                       −0.038   0.017
  Basophils       −0.056                                       0.005                                        0.033                                        0.018                                       −0.011   −0.045

*r*~s~ = Spearman correlation, BAZ = BMI-for-age *z*-score, WAZ = Weight-for-age *z*-score, HAZ = Height-for-age *z*-score, TfR = Transferrin receptor, CRP = C-reactive protein, ZnPP = Zinc protoporphyrin, RBC = red blood cell, WBC = white blood cell, MCV = Mean cell volume, Hb = Hemoglobin.

Correlation coefficient is significant at the 0.01 level (2-tailed).

Correlation coefficient is significant at the 0.05 level (2-tailed).

###### 

Correlations (*r*~s~) between markers of iron status, CRP and hematological parameters of children by gender (*N* = 556).

  Variable             Ferritin                                     CRP                                          ZnPP                                        TfR                                          Hb                                           TfR/Ferritin                                                                                                                                                                                                                                                                
  -------------------- -------------------------------------------- -------------------------------------------- ------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- ------------------------------------------- ------------------------------------------- -------------------------------------------- --------------------------------------------
  Age                  0.227[^\*\*^](#TFN7){ref-type="table-fn"}    0.295[^\*\*^](#TFN7){ref-type="table-fn"}    −0.017                                      0.099                                        0.015                                        0.055                                        −0.142[^\*^](#TFN8){ref-type="table-fn"}     −0.043                                       0.168[^\*\*^](#TFN7){ref-type="table-fn"}   0.229[^\*\*^](#TFN7){ref-type="table-fn"}   −0.226[^\*\*^](#TFN7){ref-type="table-fn"}   −0.287[^\*\*^](#TFN7){ref-type="table-fn"}
  BAZ                  0.024                                        0.094                                        0.154[^\*\*^](#TFN7){ref-type="table-fn"}   0.079                                        −0.076                                       0.238[^\*\*^](#TFN7){ref-type="table-fn"}    0.037                                        0.146                                        0.057                                       0.014                                       −0.002                                       −0.038
  WAZ                  0.045                                        0.134                                        0.102                                       0.078                                        −0.074                                       0.197                                        0.029                                        0.139                                        0.152[^\*^](#TFN8){ref-type="table-fn"}     0.084                                       −0.047                                       −0.108
  HAZ                  0.032                                        0.135                                        0.057                                       0.093                                        −0.018                                       0.042                                        0.048                                        0.049                                        0.127                                       0.127                                       −0.039                                       −0.103
  Ferritin             --                                           --                                           0.011                                       0.336[^\*\*^](#TFN7){ref-type="table-fn"}    0.093                                        −0.083                                       −0.266[^\*\*^](#TFN7){ref-type="table-fn"}   −0.292[^\*\*^](#TFN7){ref-type="table-fn"}   0.214[^\*\*^](#TFN7){ref-type="table-fn"}   0.159[^\*^](#TFN8){ref-type="table-fn"}     −0.955[^\*\*^](#TFN7){ref-type="table-fn"}   −0.977[^\*\*^](#TFN7){ref-type="table-fn"}
  TfR                  −0.266[^\*\*^](#TFN7){ref-type="table-fn"}   −0.292[^\*\*^](#TFN7){ref-type="table-fn"}   −0.008                                      −0.024                                       0.075                                        −0.011                                       −                                            −                                            0.039                                       −0.039                                      0.498[^\*\*^](#TFN7){ref-type="table-fn"}    0.469[^\*\*^](#TFN7){ref-type="table-fn"}
  TfR/Ferritin ratio   −0.955[^\*\*^](#TFN7){ref-type="table-fn"}   −0.977[^\*\*^](#TFN7){ref-type="table-fn"}   −0.008                                      −0.319[^\*\*^](#TFN7){ref-type="table-fn"}   −0.062                                       0.084                                        0.498[^\*\*^](#TFN7){ref-type="table-fn"}    0.469[^\*\*^](#TFN7){ref-type="table-fn"}    −0.170[^\*^](#TFN8){ref-type="table-fn"}    −0.161[^\*^](#TFN8){ref-type="table-fn"}    --                                           --
  CRP                  0.011                                        0.336[^\*\*^](#TFN7){ref-type="table-fn"}    --                                          --                                           0.042                                        −0.183[^\*\*^](#TFN7){ref-type="table-fn"}   −0.008                                       −0.024                                       −0.039                                      0.071                                       −0.008                                       −0.319[^\*\*^](#TFN7){ref-type="table-fn"}
  ZnPP                 0.093                                        −0.083                                       0.042                                       −0.183[^\*\*^](#TFN7){ref-type="table-fn"}   --                                           --                                           0.075                                        −0.011                                       0.055                                       −0.112                                      −0.062                                       0.084
  RBC                  0.024                                        0.009                                        −0.050                                      −0.006                                       0.069                                        −0.098                                       0.195[^\*\*^](#TFN7){ref-type="table-fn"}    0.130[^\*^](#TFN8){ref-type="table-fn"}      0.630[^\*\*^](#TFN7){ref-type="table-fn"}   0.648[^\*\*^](#TFN7){ref-type="table-fn"}   0.011                                        0.005
  WBC                  0.003                                        −0.101                                       −0.094                                      0.034                                        −0.054                                       −0.045                                       0.009                                        −0.023                                       −0.046                                      −0.046                                      −0.005                                       0.077
  Hb                   0.214[^\*\*^](#TFN7){ref-type="table-fn"}    0.159[^\*^](#TFN8){ref-type="table-fn"}      −0.039                                      0.071                                        0.055                                        −0.112                                       0.039                                        −0.039                                       --                                          --                                          −0.170[^\*^](#TFN8){ref-type="table-fn"}     −0.161[^\*^](#TFN8){ref-type="table-fn"}
  MCV                  0.197[^\*\*^](#TFN7){ref-type="table-fn"}    0.129                                        0.002                                       0.026                                        −0.023                                       0.012                                        −0.178[^\*\*^](#TFN7){ref-type="table-fn"}   −0.187[^\*\*^](#TFN7){ref-type="table-fn"}   0.324[^\*\*^](#TFN7){ref-type="table-fn"}   0.213[^\*\*^](#TFN7){ref-type="table-fn"}   −0.185[^\*^](#TFN8){ref-type="table-fn"}     −0.146[^\*^](#TFN8){ref-type="table-fn"}
  Neutrophils          −0.128                                       −0.011                                       −0.112                                      0.003                                        −0.240[^\*\*^](#TFN7){ref-type="table-fn"}   0.145[^\*^](#TFN8){ref-type="table-fn"}      −0.045                                       −0.006                                       −0.024                                      −0.039                                      0.114                                        −0.006
  Lymphocytes          −0.009                                       −0.072                                       −0.105                                      0.097                                        −0.061                                       −0.036                                       −0.014                                       0.017                                        0.079                                       −0.007                                      −0.016                                       0.081
  Monocytes            −0.072                                       0.032                                        −0.019                                      0.013                                        −0.147[^\*^](#TFN8){ref-type="table-fn"}     0.038                                        −0.054                                       0.014                                        −0.054                                      −0.010                                      0.024                                        −0.039
  Eosinophils          0.074                                        −0.107                                       0.010                                       −0.005                                       −0.076                                       0.004                                        −0.008                                       −0.010                                       0.000                                       0.030                                       −0.096                                       0.100
  Basophils            −0.075                                       −0.036                                       −0.066                                      0.002                                        −0.098                                       0.087                                        0.019                                        0.005                                        0.006                                       0.028                                       0.054                                        0.016

*r*~s~ = Spearman correlation, BAZ = BMI-for-age *z*-score, WAZ = Weight-for-age *z*-score, HAZ = Height-for-age *z*-score, TfR = Transferrin receptor, CRP = C-reactive protein, ZnPP = Zinc protoporphyrin, RBC = red blood cell, WBC = white blood cell, MCV = mean cell volume, Hb = Hemoglobin.

Correlation coefficient is significant at the 0.01 level (2-tailed).

Correlation coefficient is significant at the 0.05 level (2-tailed).

In the total group when comparing children with low SF (SF \<12 μg/L) and those with high SF (SF ⩾12 μg/L), the only difference observed was with eosinophils which were higher in the low SF group (0.38; \[IQR 0.44\]) than in the high SF group (0.30; \[IQR 0.31\]) (*p* = 0.026). Splitting the children by gender showed no differences in boys, but did in girls. There were differences in lymphocytes (*p* = 0.033) with the low SF group recording higher values (3.26; \[IQR 1.38\]) than the high SF group (2.88; \[IQR 0.95\]). The same was observed with eosinophils (*p* = 0.011) with the low SF group recording higher values (0.40; \[IQR 0.54\]) than the high SF group (0.27; \[IQR 0.28\]).

4.. Discussion {#s4}
==============

In this study, the associations between iron status and WBC counts of healthy South African schoolchildren were examined. The study generally showed no relationships between iron status and WBC counts in this population. There were significant gender differences in the population with regard to the distribution of CRP, RBC and Hb. With regard to iron deficiency, though not significant, boys tended to have higher prevalence rates which are contrary to previous findings where girls have been shown to be more anemic \[[@B23]\].

This study showed no association between the measured iron markers and some immune variables (differentiated WBC). A number of studies have found that several immune parameters are affected during iron deficiency, especially cell-mediated immunity and bactericidal activity of neutrophil granulocytes \[[@B17],[@B24]\]. In this study this was not the case probably because the sample was drawn from a subpopulation of children with low prevalence of iron deficiency ([Table 2](#T2){ref-type="table"}). According to Chandra \[[@B24]\], the ability of blood neutrophils and peritoneal macrophages to kill ingested bacteria and fungi is reduced in iron-deficient individuals and is associated with alterations in intracellular metabolic activity. Conversely, in a study among homebound, older women in Pennsylvania, no differences were seen between the iron-sufficient and iron-deficient groups with respect to total lymphocytes or their subpopulations, granulocytes, or Monocytes, when they were expressed as absolute counts or percentages \[[@B19]\]. Krause et al., \[[@B25]\] have also shown that several immune parameters, including circulating T-lymphocyte number, natural killer cell cytotoxicity, phagocytosis, and bactericidal function, did not differ in generally healthy and well-nourished women. Lesourd \[[@B26]\] reported that these changes in the immune system are more important in populations that are not well nourished and in populations who exhibit decreased iron status mainly because immune responses are related to health status. This could explain why there were no associations observed between the iron markers and immune parameters in this study population.

This study demonstrated a positive association between SF and CRP in girls. Numerous studies of iron status conducted in developing countries have used biomarkers of inflammation to determine the influence of this inflammation on markers of iron-status \[[@B27]--[@B29]\]. SF is an acute phase reactant which is elevated during inflammation \[[@B30]\]. These associations could be a result of the weight differences observed to be higher in girls. Other studies in the literature have confirmed the association between weight and CRP and pointed toward BMI as a major contributor to the observed variation in CRP levels in different populations \[[@B31]--[@B34]\]. But, surprisingly, there were no differences in BAZ between boys and girls in this study. BMI now recognized as an inflammatory marker \[[@B35],[@B36]\] may have contributed indirectly to the observed positive association between SF levels and CRP in girls. The weight differences between boys and girls could serve as an additional explanation for the positive association between SF and CRP. However, it was odd to find that hemoglobin levels were higher in girls than in boys while it is known that at this age there are no significant gender differences.

It is also known that MCV is a marker of iron deficiency erythropoiesis; as such its relationship with TfR is in agreement with previous findings which have shown that red cell parameters decreased gradually with increasing negative iron balance as iron deficiency occurred \[[@B23]\]. However, it is hard to explain the relationship between MCV and SF only in boys. But it is possible that since it is also an iron marker, the relationship is related to that of its receptor. It is also worthwhile to note that boys had slightly higher percentages of those who were iron deficient though this was not statistically significant. Recent evidence seems to be pointing to the direction that improving iron status in children may be a potential risk in stimulating the development of infection \[[@B37],[@B38]\]. Although iron supplementation improves cognition and growth in deficient children \[[@B39]--[@B42]\], this may not be so when improving immune function in a healthy population as the increased available iron may be harmful through the proliferation of bacteria by the iron concentration of the culture medium \[[@B43]\] and iron supplements can produce oxidative stress and cause damage to cells mediated through free radicals \[[@B44]\]. Because iron is not easily eliminated from the body, attention has to be paid to circumstances in which excess iron may be absorbed or used inappropriately. In Africa, infections are a major factor when considering supplementation because of the potential risk that improving iron status may have on bacterial growth, especially in healthy children. Oppenheimer et al., \[[@B45]\] have previously reported increased infection rates after iron intervention.

5.. Conclusion {#s5}
==============

It is concluded that there are no associations between the measured iron markers and white blood cell counts in healthy children that participated in the BeForMi study. It is thus possible that in healthy children, the association is shielded or that the population has a different genotype, an area that needs to be explored further. Furthermore, this highlights the need for studies around the issue of supplementing iron sufficient children to explore whether this is beneficial or detrimental to them with respect to their immune function (especially the reported increases in infection rates) \[[@B45]\] and weighing against the fact that iron supplementation improves cognitive development.

The present study was supported by grants from the Coca-Cola Company. We would like to thank all the staff members within the Centre of Excellence for Nutrition who participated in the data collection, especially Mrs. E. Rossouw and Mrs. L. Malan for the laboratory analysis. We are also grateful to Sr. MC Lessing for her assistance during blood collection. All the authors (Onabanjo OO, Jerling JC, Namukolo C, van Graan A, Taljaard C, Mamabolo RL) contributed to the research work during the data collection and final article write-up. There are no supplementary materials submitted on line; neither is there any potential conflict of interest.

Conflict of interest
====================

There are no supplementary material submitted on line neither is there any potential conflict of interest. The article contains no libelous or unlawful statement none infringe upon anyone else's copyright.
